Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors
Anthony A. Kossiakoff
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorWilliam Somers
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorMark Ultsch
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorKerrie Andow
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorYves A. Muller
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorCorresponding Author
Abraham M. De Vos
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080Search for more papers by this authorAnthony A. Kossiakoff
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorWilliam Somers
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorMark Ultsch
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorKerrie Andow
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorYves A. Muller
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Search for more papers by this authorCorresponding Author
Abraham M. De Vos
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, California 94080Search for more papers by this authorAbstract
The crystal structures of complexes of human growth hormone (hGH) with the growth hormone and prolactin receptors (hGHR and hPRLR, respectively), together with the mutational data available for these systems, suggest that an extraordinary combination of conformational adaptability, together with finely tuned specificity, governs the molecular recognition processes operative in these systems. On the one hand, in the active 1:2 ligand-receptor complexes, 2 copies of the same receptor use the identical set of binding determinants to recognize topographically different surfaces on the hormone. On the other hand, comparing the 1:1 hGH-hGHR and hGH-hPRLR complexes, 2 distinct receptors use this same set of binding determinants to interact with the identical binding site on the ligand, even though few residues among the binding determinants are conserved. The structural evidence demonstrates that this versatility is accomplished by local conformational flexibility of the binding loops, allowing adaptation to different binding environments, together with rigid-body movements of the receptor domains, necessary for the creation of specific interactions with the same binding site.
References
- Abdel-Meguid SS, Shieh HS, Smith WW, Dayringer HE, Violand BN, Bentle A. 1987. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc Natl Acad Sci USA 84: 6434–6437.
- Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell 73: 431–445.
- Bass SH, Mulkerrin MM, Wells JA. 1991. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88: 4498–4502.
- Baumann G, Lowman HB, Mercado M, Wells JA. 1994. The stoichiometry of growth hormone-binding protein complexes in human plasma: Comparison with cell surface receptors. J Clin Endocrinol Metab 78: 1113–1118.
- Bazan JF. 1990. Structural design of molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934–6938.
- Boulay JL, Paul WE. 1993. Hematopoietin sub-family classification based on size, gene organization and sequence homology. Curr Biol 3: 573–581.
- Chawla RK, Parks JS, Rudman D. 1983. Structural variants of human growth hormone: Biochemical, genetic and clinical aspects. Annu Rev Med 34: 519–547.
- Chiba T, Amanuma H, Tokodoro K. 1992. Tryptophan residue of Trp-Ser-X-Trp-Ser motif in extracellular domains of erythropoietin receptor is essential for signal transduction. Biochem Biophys Res Commun 184: 485–490.
- Cosman D. 1993. The hematopoietin receptor superfamily. Cytokine 5: 95–106.
- Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254: 821–825.
- Cunningham BC, Wells JA. 1989. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244: 1081–1085.
- Cunningham BC, Wells JA. 1991. Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88: 3407–3411.
- Cunningham BC, Wells JA. 1993. Comparison of a structural and a functional epitope. J Mol Biol 234: 554–563.
- De Vos AM, Kossiakoff AA. 1992. Receptor action and interaction. Curr Opin Struct Biol 2: 852–858.
- De Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255: 306–312.
- Fuh G, Colosi P, Wood WI, Wells JA. 1993. Mechanism-based design of prolactin receptor antagonists. J Biol Chem 268: 5376–5381.
- Hintz HJ. 1983. Thermodynamics of protein-ligand interactions: Calorimetric approaches. Annu Rev Biophys Bioeng 12: 285–317.
- Huber AH, Wang YM, Bieber AJ, Bjorkman PJ. 1994. Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 Å. Neuron 12: 717–731.
- Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATSs. Trends Biochem Sci 19: 222–227.
- Kaushandy K, Karplus PA. 1993. Hematopoietic growth factors: Understanding functional diversity in structural terms. Blood 82: 3229–3241.
- Leahy DJ, Hendrickson WA, Aukhil I, Erickson HP. 1992. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science 257: 987–991.
- Lowman HB, Wells JA. 1993. Affinity maturation of human growth hormone by monovalent phage display. J Mol Biol 234: 564–578.
- Miyazaki T, Maruyama M, Yamada G, Hatakeyama M, Taniguchi T. 1991. The integrity of the conserved WS motif common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J 10: 3191–3197.
- Müller YA, Ultsch M, Kelley RF, De Vos AM. 1994. Structure of the extracellular domain of tissue factor: Location of the factor VIIa binding site. Biochemistry. Forthcoming.
- Nicoll CS, Mayer GL, Russell SM. 1986. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocrine Rev 7: 169–203.
- Patthy L. 1990. Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin. Cell 61: 13–14.
- Ross PD, Subramanian S. 1981. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry 20: 3096–3107.
- Rozakis-Adcock M, Kelly PA. 1992. Identification of ligand binding determinants of the prolactin receptor. J Biol Chem 267: 7428–7433.
- Somers W, Ultsch M, De Vos AM, Kossiakoff AA. 1994. The X-ray structure of the growth hormone-prolactin receptor complex: Receptor binding specificity developed through conformational variability. Nature. Forthcoming.
- Sprang SR, Bazan JF. 1993. Cytokine structural taxonomy and mechanisms of receptor engagement. Curr Opin Struct Biol 3: 815–827.
- Ultsch M, De Vos AM. 1993. Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent receptor dimerization. J Mol Biol 231: 1133–1136.
- Ultsch M, Somers W, Kossiakoff AA, De Vos AM. 1994. The crystal structure of affinity-matured human growth hormone at 2 Å resolution. J Mol Biol 236: 286–299.
- Wells JA, De Vos AM. 1993. Structure and function of human growth hormone: Implications for the hematopoietins. Annu Rev Biophys Biomol Struct 22: 329–351.